Additionally, Clearwater will pay $30 million to terminate Enfusion’s tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion. This press release features ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback